Research Fellow and Principal Investigator
Paul Liknaitzky, Ph.D.
Turner Institute (School of Psychological Sciences) and Dept of Psychiatry (School of Clinical Sciences), Monash University
Paul Liknaitzky is Head of Clinical Psychedelic Research at Monash University, and Chief Principal Investigator on a program of psychedelic trials. He is a Research Fellow within both the Turner Institute and the Dept of Psychiatry at Monash University, and earned an Honours in Neuroscience and a PhD in Psychology from the University of Melbourne. In Australia, he is an Investigator on several of the country’s initial psychedelic trials, has coordinated a number of psychedelic therapist training and supervision programs, obtained the first industry funding for psychedelic science, and leads the first clinical psychedelic lab. His work is focused on developing a rigorous program of research in clinical psychedelics that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.